Sana Biotechnology (SANA)

• Market cap: $889M
• 1 day: 7.77%
• 5 days: 8.12%
• 1 month: -13.51%
• 3 months: -34.45%
• 6 months: 3.1%
• Year to date: -20.53%
• 1 year: 25.19%
• 5 years: -88.66%
• 10 years: -90.51%
• Sector: Healthcare
• Industry: Biotechnology

About: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Employees: 142